Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


7 - 9 November 2017
Austria Trend Eventhotel Pyramide,

Improve delivery and drive products to market through expert insight, new data and technology for oligonucleotide therapeutics

Thank you to everyone who attended this year's conference

Thank you for attending EuroTIDES

The EuroTIDES team would like to extend a huge thank you to the 260+ oligonucleotide and peptide experts who joined us in Berlin in November. 

Across 4 days attendees benefited from expert insight on how to improve delivery of oligonucleotides and drive these products to market. Additionally, networking opportunities were plentiful with over 130 meetings being organised via the conference app.

Mark your calendar

Next year we will be in our new location of Austria on 7-9 November 2017, for more information please email

Advance your Oligonucleotide Therapeutics towards Commercial Success

Decision Makers
Companies from the Oligonucleotide and Peptide Industry
Buyer: Seller Ratio

With Thanks to the EuroTides 2016 Scientific Advisory Board:

  • Troels Koch, VP & Head of Research, RNA Therapeutics, Roche Innovation Center Copenhagen A/S, Denmark
  • Thomas Rupp, Owner, Thomas Rupp Consulting, Germany
  • Yogesh Sanghvi, President, Rasayan, USA
  • Brian Sproat, Managing Director, Chemconsilium, Belgium
  • Cy Stein, Department of Medical Oncology and Experimental Therapeutics, City of Hope Medical Center, USA
  • Stefan Vonhoff, Vice President CMC, Noxxon Pharma AG, Germany
  • Muthiah (Mano) Manoharan, Senior VP, Drug Discovery, Alnylam Pharmaceuticals, Inc, USA
  • Mike Gait, MRC Programme Leader, MRC Laboratory of Molecular Biology, UK